Acadia Pharmaceuticals is putting the power of storytelling to work for Parkinson’s disease. While storytelling in general is often used in pharma marketing to help explain the realities of health…
Reps. Fred Upton (R-MI) and Diana DeGette (D-CO) on Tuesday unveiled the second iteration of their mammoth 21st Century Cures Act, a wide-ranging, mostly pro-pharma law signed by former President…
By most accounts, the biotech sector has boomed throughout the Covid-19 pandemic, particularly for companies looking to go public through a traditional IPO or the ever-more-popular SPAC route. But as…
If you thought Pfizer was raking it in with megablockbuster sales of its BioNTech-partnered Covid-19 vaccine — last projected at $36 billion for 2021 — think again. As the pharma giant sends off its…
The House Energy & Commerce Committee began marking up a dozen bills on Wednesday morning including one that would require the FDA to craft a five-year action plan for fostering the development of…
Smallpox was declared eradicated in 1980 by the World Health Organization, after an effort to vaccinate the globe. But several vials labeled as the disease were found at a Pennsylvania vaccine…
Now that President Joe Biden has drug his heels as long as possible in selecting a new FDA commissioner, we’re set to welcome the new boss — same as the old boss. Janet Woodcock, whose public legacy…
Frank D’Amelio, Pfizer’s legendary chief financial officer of the last 15 years, would often say his job was about understanding the ‘rhythm of the numbers.’ Now — as the company’s on track to drum up…
Following an oral explanation held at the November meeting of the EMA’s human medicines committee, Biogen received
Ahead of expected objections by European regulators Wednesday to its deal to acquire Grail, Illumina defended itself in papers submitted to the agencies Tuesday. Illumina is anticipating a formal bloc…
